Written description of three observable trends based on the data.
When compared to infubinol, ketapril and placebo, the drug capomulin exhibited the following: (1) The lowest metastatis (or greatest inhibitory effect) during treatment. (2) The highest murine survival rate from day 10 forward. (3) A drecrease in tumor volume (~19%) over a 45-day treatment period.